Winton Group’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.53M Sell
159,508
-10,198
-6% -$274K 0.18% 135
2026
Q1
$3.52M Buy
+169,706
New +$4.01M 0.12% 221
2024
Q3
Sell
-16,441
Closed -$332K 694
2024
Q2
$332K Buy
+16,441
New +$274K 0.02% 475
2024
Q1
Sell
-16,966
Closed -$151K 722
2023
Q4
$151K Sell
16,966
-1,696
-9% -$12.5K 0.01% 674
2023
Q3
$117K Sell
18,662
-7,138
-28% -$53.1K 0.01% 710
2023
Q2
$243K Sell
25,800
-9,073
-26% -$90K 0.02% 605
2023
Q1
$346K Buy
+34,873
New +$306K 0.02% 787
2022
Q3
Sell
-56,384
Closed -$255K 1007
2022
Q2
$255K Buy
+56,384
New +$240K 0.01% 840

Other funds holding HIMS

Winton Group's HIMS Position: Q2 2026 in Review

Winton Group reduced its Hims & Hers Health (HIMS) stake by 6% in Q2 2026, selling an estimated $274K and leaving 159,508 shares worth $5.53M. The position accounts for 0.18% of the portfolio, ranked #135.

Winton Group first reported a position in HIMS in Q2 2022 and has held it in 8 quarters since. 505 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Winton Group held 159,508 shares of Hims & Hers Health worth $5.53M as of Q2 2026.
  • Winton Group sold 10,198 Hims & Hers Health shares in Q2 2026, an estimated $274K.
  • Hims & Hers Health made up 0.18% of Winton Group's portfolio in Q2 2026, its #135 holding.
  • Winton Group first reported a position in Hims & Hers Health in Q2 2022 and has held it in 8 quarters since.
  • 505 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.